Trial Outcomes & Findings for Feasibility Study of the Magnetic Anal Sphincter (FENIX System) (NCT NCT01625221)

NCT ID: NCT01625221

Last Updated: 2018-01-03

Results Overview

The safety objective will be met via reporting all adverse events at various time points including implant, 6 weeks, 3 months, 6 months, and 12 months (and then semi-annually until 5 years post-implant at U.S. sites). Serious device- and procedure-related adverse events will be summarized separately. Safety will be characterized by physical examination and pelvic X-ray evaluations.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

35 participants

Primary outcome timeframe

60 months

Results posted on

2018-01-03

Participant Flow

Participant milestones

Participant milestones
Measure
Magnetic Anal Sphincter Augmentation
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Overall Study
STARTED
35
Overall Study
COMPLETED
28
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Feasibility Study of the Magnetic Anal Sphincter (FENIX System)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Magnetic Anal Sphincter Augmentation
n=35 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Age, Continuous
64.1 years
STANDARD_DEVIATION 9.7 • n=5 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
18 Participants
n=5 Participants
Age, Categorical
>=65 years
17 Participants
n=5 Participants
Sex: Female, Male
Female
34 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
Region of Enrollment
France
15 participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants
Region of Enrollment
Denmark
5 participants
n=5 Participants
Fecal incontinence episodes
13.9 episodes per week
STANDARD_DEVIATION 6.7 • n=5 Participants

PRIMARY outcome

Timeframe: 60 months

Population: All adverse events as reported by investigators

The safety objective will be met via reporting all adverse events at various time points including implant, 6 weeks, 3 months, 6 months, and 12 months (and then semi-annually until 5 years post-implant at U.S. sites). Serious device- and procedure-related adverse events will be summarized separately. Safety will be characterized by physical examination and pelvic X-ray evaluations.

Outcome measures

Outcome measures
Measure
Magnetic Anal Sphincter Augmentation
n=35 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Adverse Events
All Adverse Events
223 Number of events
Adverse Events
Serious Device or Procedure-related Adverse Events
7 Number of events

PRIMARY outcome

Timeframe: 12 Months

Effectiveness will be characterized as the reduction of FI symptoms by subjective measurements using the FISI, Wexner, and FIQOL scores and a three week diary documenting episodes of incontinence.

Outcome measures

Outcome measures
Measure
Magnetic Anal Sphincter Augmentation
n=28 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Reduction in Fecal Incontinence Symptoms
3.8 episodes per week
Standard Deviation 5.1

Adverse Events

Magnetic Anal Sphincter Augmentation

Serious events: 6 serious events
Other events: 12 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Magnetic Anal Sphincter Augmentation
n=35 participants at risk
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Infections and infestations
Infection
11.4%
4/35
Skin and subcutaneous tissue disorders
Device erosion
2.9%
1/35
Gastrointestinal disorders
Impaction or defecatory disorder
2.9%
1/35
Immune system disorders
Allergy, inflammation reaction
2.9%
1/35

Other adverse events

Other adverse events
Measure
Magnetic Anal Sphincter Augmentation
n=35 participants at risk
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision. Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Skin and subcutaneous tissue disorders
Device erosion
8.6%
3/35
Gastrointestinal disorders
Pain
17.1%
6/35
Gastrointestinal disorders
Impaction or defecatory disorder
5.7%
2/35
Gastrointestinal disorders
Rectal bleeding
2.9%
1/35

Additional Information

VP of Clinical Affairs

Torax Medical, Inc.

Phone: 651-361-8900

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60